Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cardioprotective effects of K-7259 in rat hearts

June 2, 1997

Lilly describes agents for Alzheimer's disease

June 2, 1997

Antimigraine agents from Janssen

June 2, 1997

MS&D prepares CCK-B/gastrin receptor antagonists

June 2, 1997

Anxiolytic/nootropic agents from Asahi

May 30, 1997

Antiemetics described by Dainippon

May 30, 1997

Otsuka reports analgesic agents

May 28, 1997

Favorable hemodynamic profile of aptiganel during general anesthesia

May 27, 1997

Fujisawa and Solvay sign marketing agreement for antidepressant

May 27, 1997

Promising data from pivotal trials of Actiq reported at ASCO

May 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...